Company

Pharmanutra S.p.A.

Headquarters: Pisa, PI, Italy

Employees: 64

MTA: PHN -0.88%

Market Cap

€460.6 Million

EUR as of July 1, 2024

US$494.7 Million

Market Cap History

Pharmanutra S.p.A. market capitalization over time

Evolution of Pharmanutra S.p.A. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Pharmanutra S.p.A.

Detailed Description

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, rest of Europe, the Middle East, Far East, and internationally. The company also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and food supplement industries. Its products primarily include SiderAL, SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med, Cetilar Crema, Cetilar Patch, Tape, ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. The company distributes and sells its products through sales representatives, wholesalers, pharmacies, and para-pharmacies. Pharmanutra S.p.A. was founded in 2003 and is based in Pisa, Italy.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Pharmanutra S.p.A. has the following listings and related stock indices.


Stock: MTA: PHN wb_incandescent

Stock: FSX: 761 wb_incandescent

Details

Headquarters:

Via delle Lenze 216/B

Pisa, PI 56122

Italy

Phone: 39 05 07 84 65 00

Fax: 39 05 07 84 65 24